Spermatogenesis relies on coordinated differentiation of stem and progenitor spermatogonia, and the transcription factor STAT3 is essential for this process in mammals. Here we studied the THY1+ spermatogonial population in mouse testes, which contains spermatogonial stem cells (SSC) and non-stem cell progenitor spermatogonia, to further define the downstream mechanism regulating differentiation. Transcript abundance for the bHLH transcription factor Neurog3 was found to be significantly reduced upon transient inhibition of STAT3 signaling in these cells and exposure to GDNF, a key growth factor regulating self-renewal of SSCs, suppressed activation of STAT3 and in accordance Neurog3 gene expression. Moreover, STAT3 was found to bind the distal Neurog3 promoter/enhancer region in THY1+ spermatogonia and regulate transcription. Transient inhibition of Neurog3 expression in cultures of proliferating THY1+ spermatogonia increased stem cell content after several self-renewal cycles without effecting overall proliferation of the cells, indicating impaired differentiation of SSCs to produce progenitor spermatogonia. Furthermore, cultured THY1+ spermatogonia with induced deficiency of Neurog3 were found to be incapable of differentiation in vivo following transplantation into testes of recipient mice. Collectively, these results establish a mechanism by which activation of STAT3 regulates the expression of NEUROG3 to subsequently drive differentiation of SSC and progenitor spermatogonia in the mammalian germline. differentiation, NEUROG3, progenitor spermatogonia, spermatogonia, spermatogonial stem cell, STAT3
INTRODUCTION
Tissue-specific stem cells and progenitors are responsible for maintaining homeostasis during steady-state conditions and regeneration of tissue lineages after cytotoxic injury [1] . The rare stem cells are defined by the ability to self-renew for maintaining and replenishing a stem cell pool, as well as production of progenitors that are committed to further differentiation, ultimately providing tissue-specific functionality. Thus, two levels of differentiation occur during early development of cell lineages, the first being initial differentiation of stem cells to generate progenitors and the second being continued development of progenitors to eventually produce mature cells. Dysregulation of stem and progenitor cell functions could lead to loss of homeostasis and aging-related decline of tissue function [2] ; thus, deciphering mechanisms controlling differentiation is important for potentially diagnosing and treating a variety of degenerative diseases.
Spermatogenesis is a classic model of tissue-specific stem cell activity, relying on self-renewal and differentiation of spermatogonial stem cells (SSCs) to support male fertility from puberty until old age [3, 4] . In mammalian testes, type A single (A s ) spermatogonia are widely considered to represent the SSC population. Initial differentiation of SSCs produces progenitor germ cells termed A paired (A pr ) and A aligned (A al ) spermatogonia that develop further to generate differentiating spermatogonia that are committed to eventual formation of spermatozoa [3, 4] . Deciphering mechanisms controlling SSC and progenitor spermatogonia functions is important to better understand regulation of spermatogenesis and treat certain instances of male infertility. In addition, information gained from studying these cells may be applicable to stem and progenitor cell populations of other tissue lineages.
Self-renewal of SSCs is regulated by the cytokine glial cell line-derived neurotrophic factor (GDNF) to maintain a stem cell pool [5, 6] . Previous studies identified genes that are upregulated by GDNF signaling in SSCs, and several of these have been shown to play important roles in controlling selfrenewal [7, 8] . On the other hand, molecular mechanisms regulating differentiation of SSC and progenitor spermatogonia are poorly defined. Our previous studies revealed that expression of the transcription factor signal transducer and activator of transcription 3 (STAT3) is essential for both initial differentiation of SSCs and further differentiation of progenitor spermatogonia, but the downstream targets of STAT3 activation remain undefined [9] . Also, studies by Yoshida and colleagues [10] showed that the expression level of the basic helix-loop-helix (bHLH) transcription factor neurogenin 3 (Neurog3) increases with formation of A pr /A al progenitor spermatogonia, yet a functional role in regulating differentiation has not been determined.
Mechanistic study of molecular pathways controlling SSC fate decisions is challenging in mammalian testes due to relative rarity of these cells compared to the more abundant differentiated germ cell types. Thus, isolated testis cell populations enriched for SSC and progenitor spermatogonia are an important tool, particularly the thymus cell antigen 1 (THY1)-expressing germ cell fraction, which is composed of SSC and non-stem cell progenitor spermatogonia and is enriched 30-fold for stem cells in testes of adult mice [6] . In addition, THY1þ germ cells can be maintained in vitro for long periods of time as a proliferative germ cell population composed of SSC and progenitor spermatogonia [11] . In these cultures, exposure to GDNF is required for the self-renewal of SSCs [6, 11] , and initial differentiation occurs to generate A pr / A al -like progenitor spermatogonia [9] . Furthermore, transplantation analysis can be used with these cultures to examine effects of experimental manipulations on the maintenance of SSCs specifically and ability of SSC/progenitors to differentiate and reestablish spermatogenesis [8, 9] . In this study, we used the THY1þ germ cell fraction in conjunction with culture and transplantation methodologies to test the hypothesis that Neurog3 is a downstream target of STAT3 transcriptional activation and has an important role in controlling differentiation of SSC and progenitor spermatogonia.
MATERIALS AND METHODS

Animals
Cultures of THY1þ spermatogonia were established from B6.129S7-GtROSA26Sor/J mice (designated Rosa; Jackson Laboratory), which express the LacZ transgene in all germ cells, allowing for identification of reestablished donor-derived spermatogenesis following germ cell transplantation. Recipient mice for germ cell transplantation assays were immunologically compatible F 1 progeny of 129SvCP 3 C57BL/6J mice. Experiments not involving cultured THY1þ germ cells or germ cell transplantation were conducted with germ cells or tissues from inbred C57BL/6J mice (Jackson Laboratory). All animal procedures were approved by the Pennsylvania State University and Washington State University Institutional Animal Care and Use Committees.
Chromatin Immunoprecipitation
Physical interaction of STAT3 protein with Neurog3 promoter/enhancer DNA within freshly isolated THY1þ germ cells of adult mice was examined using the ExactaChIP Human/Mouse STAT3 chromatin immunoprecipitation (ChIP) kit following manufacturer instructions (R&D Systems). Briefly, after being isolated from adult testes, 5 3 10 6 THY1þ germ cells were fixed with 1% formaldehyde in PBS, to cross-link protein-DNA complexes, and lysed with 500 ll of lysis buffer (R&D Systems). Samples were sonicated using a Sonifier 250 cell disruptor (Branson Ultrasonics Corp., Danbury, CT) to fragment genomic DNA to the size of ;1 kb. Lysates were collected via centrifugation, diluted with dilution buffer (R&D Systems), and incubated with sheep antihuman/mouse STAT3 antibody conjugated to biotin (5 ll per 5 3 10 6 lysed cells; R&D Systems) overnight at 48C with rotation. Negative controls were cells incubated with biotinylated normal sheep immunoglobulin G (IgG) in place of the primary antibody (R&D Systems). Lysates were then incubated with streptavidin-conjugated agarose beads (Sigma-Aldrich) to precipitate protein-DNA complexes. Chelating resin solution (R&D Systems) was then added to precipitated complexes to dissociate DNA from protein, and DNA fragments were purified using DNeasy DNA purification kit (Qiagen). PCR was conducted with primers designed to recognize a 200-bp fragment of the distal Neurog3 promoter/enhancer region beginning at À3748 bp upstream of the transcriptional start site (primer pair 5 0 GTTGGTGAGCCCCTGGAG ACCATAT 3 0 and 5 0 CTGGCCCCTGGCCCCTGGGCAC 3 0 ). PCR products were separated on a 0.9% agarose gel and imaged using the ChemiDoc XRS molecular imager system (Bio-Rad Laboratories). Positive controls consisted of PCR with validated primers for the v-myc myelocytomatosis viral oncogene homolog (Myc) promoter region, a known target of STAT3 binding [12] .
Quantitative ChIP analyses were performed as described previously [13] . Briefly, a standard number of 3 3 10 5 cultured THY1þ spermatogonia were subjected to treatments and processed for STAT3 ChIP as described above. DNA samples were then analyzed by quantitative PCR (qPCR) using primers spanning the Neurog3 promoter/enhancer region and SYBR Green DNA binding dye. The resulting threshold cycle (C t ) value for each sample was normalized to the C t of input DNA from cultured THY1þ spermatogonia not subjected to any treatments. Relative abundance values were calculated for each sample to compare means, using the formula: relative abundance ¼ 0. 
Fluorescent Immunocytochemistry
Freshly isolated or cultured THY1þ germ cells were adhered to poly-Llysine-coated coverslips and fixed with 4% paraformaldehyde followed by incubation in PBS with 0.1% Triton X-100 (PBS-T) to permeabilize membranes. Nonspecific antibody binding was blocked by incubating cells in 10% normal goat or donkey serum in PBS-T for 1 h at room temperature. Rabbit anti-mouse NEUROG3 primary antibody (1.33 lg/ml; Santa Cruz Biotechnology) or goat anti-mouse p-STAT3 Tyr705 primary antibody (1.33 lg/ ml; Cell Signaling Technology) was added to the cells and incubated overnight at 48C. Cells incubated with normal rabbit or goat IgG (1.33 lg/ml; Santa Cruz Biotechnology) in place of primary antibody served as negative controls. For secondary labeling, cells were incubated with goat anti-rabbit IgG antibody conjugated to AlexaFluor 488 (Invitrogen), donkey anti-rabbit IgG antibody conjugated to AlexaFluor 546 (Invitrogen), or donkey anti-goat IgG antibody conjugated to AlexaFluor 488 (Invitrogen) for 1 h at 48C, followed by mounting coverslips onto glass slides with Vectashield medium containing 4 0 ,6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Inc.). Cells were examined for NEUROG3 and p-STAT3 Tyr705 staining by using an IX51 model inverted fluorescence microscope (Olympus), and digital images were captured with a DP72 camera (Olympus) using Cell Sense software (Olympus). Five different fields of view per coverslip were examined to quantify total cell number (determined by DAPI staining), p-STAT3 Tyr705 -expressing cells, and NEUROG3-expressing cells. The percentage of total cells expressing NEUROG3 or p-STAT3 Tyr705 was determined by dividing by the total number cells (i.e., DAPI-stained nuclei).
Germ Cell Transplantation Analyses
Transplantation of cultured LacZ-expressing Rosa THY1þ germ cells was conducted to assay for stem cell content of experimental germ cell populations following small interfering RNA (siRNA) treatments or the ability of Neurog3-specific small hairpin RNA (shRNA)-treated cells to reestablish spermatogenesis as described previously [9] . Cultured Rosa THY1þ germ cells were collected by trypsin-ethylenediaminetetraacetic acid (EDTA) digestion to generate single cell suspensions and suspended in mouse serum-free media (mSFM) at a standard concentration of 2 3 10 6 cells/ml. Approximately 7 ll of cell suspension was infused into seminiferous tubules via the rete testis of recipient mice that were previously pretreated with busulfan (60 mg/kg of body weight) for at least 6 weeks to deplete endogenous spermatogenesis. Colonies of donor-derived spermatogenesis in testes of recipient mice derived from transplanted SSCs were examined at least 6 weeks after transplantation by Xgal (5-bromo-4-chloro-indolyl-b-D-galactopyranoside) staining. Colonies were counted manually using an SZ51 dissecting microscope (Olympus), and images were captured using an SZX10 microscope (Olympus) equipped with a DP71 camera (Olympus). For siRNA treatment, SSC content was determined based on colonies of donor-derived spermatogenesis generated per 1 3 10 5 germ cells transplanted.
Isolation and Culture of THY1þ Germ Cells
THY1þ germ cells were collected from donor pups at 6-8 days postpartum (dpp) and 3 month-old adult mice, using magnetic-activated cell sorting (MACS) as described previously [11, 14] . Seminiferous tubules of pup testes were digested into single-cell suspensions by incubation with 0.25% trypsin-EDTA (Invitrogen) and DNase (7 mg/ml; Sigma-Aldrich) at 378C for 10 min. Adult testes were first incubated with collagenase type IV (1 mg/ml; Worthington Biochemical), followed by washing in Hanks buffered saline solution to separate seminiferous tubules and remove interstitial cells before digestion with trypsin-EDTA and DNase. Clumps of cells and debris were then removed by passing the cell suspension through a 40-lm-pore cell strainer. Resulting single-cell suspensions were subjected to density fractionation using a 30% Percoll (Sigma-Aldrich) gradient, and the bottom pellet was dispersed and incubated with rat anti-mouse THY1 antibody conjugated to magnetic microbeads (50 ll/ml; Miltenyi Biotech) for 30 min, again pelleted by centrifugation at 600 3 g for 7 min, and washed in PBS to remove residual antibody. The cell suspension was then subjected to fractionation using MACS separation columns for isolation of THY1þ cells (Miltenyi Biotech). For primary cultures, THY1þ germ cells were suspended in mSFM [6, 11] supplemented with recombinant human GDNF (20 ng/ml; R&D Systems) and recombinant human FGF2 (1 ng/ml; BD Biosciences). Cells were seeded onto mitotically inactivated LIF-secreting STO feeder cell monolayers and maintained in humidified incubators at 378C with an atmosphere of 5% CO 2 in air. Medium with growth factors was changed every other day, and cultures were passaged every 7 days onto fresh STO feeder cell monolayers at 1:2 to 1:3 dilutions. Under these conditions, cultured THY1þ germ cells form clumps which contain both SSC and non-stem cell progenitor spermatogonia [11] .
Luciferase Promoter Assay
The ability of phosphorylated STAT3 to bind the Neurog3 promoter/ enhancer region and regulate transcription was assessed using a dual firefly and Renilla luciferase assay. HeLa cells were cotransfected with 500 ng of either control pGL3-Basic plasmid (Promega) or pGL3 containing a 3957-bp portion KAUCHER ET AL. of the Neurog3 promoter/enhancer region upstream of the firefly luciferase gene (pGL3-Neurog3 Luc) plasmid [15] and 1 ng of Renilla luciferase plasmid (pGL4.71 [hRlucP] Vector; Promega) as a control, using Lipofectamine-2000 reagent (Invitrogen) in Opti-MEM medium (Invitrogen). After 8 h, Opti-MEM was replaced by DMEM supplemented with a 1% penicillin-streptomycin solution (Invitrogen) and a 1% fetal bovine serum (Invitrogen). After cells were transfected, they were subjected to treatment with interferon-alpha (IFNA; 100 U/ml; R&D Systems) for 18 h to activate STAT3 signaling, followed by treatment with either STAT3 inhibiting peptide or inactive control peptide (5 lg/ml; Sigma) for 30 min. Luciferase activity was assayed with the dualluciferase assay system kit (Promega) and measured using the luciferase assay protocol with a GloMax-multi detection system (Promega). The ratio of reporter activity (firefly) to internal control activity (Renilla) was used to determine a relative luciferase unit (RLU) for comparison between treatments.
Transduction of Cultured THY1þ Spermatogonia with shRNA Lentiviral Vectors Lentiviral plasmid vectors containing shRNA transgenes were produced from commercially available plasmids (Sigma-Aldrich). The pLKO.1-puro plasmid backbone for these vectors contains the human U6 promoter to drive constitutive transcription of shRNA sequences and the puromycin resistance gene for selection of cells with stable incorporation of the transgene. For production of lentiviral particles, control or Neurog3-specific shRNA plasmid was cotransfected along with envelope (pMD2.G) and packaging (psPAX2) plasmids into HEK293 cells (ATCC) using Lipofectamine 2000 reagent (Invitrogen). Samples of culture medium containing lentiviral particles were collected for 96 h after transfection, and particles were concentrated by ultracentrifugation through a 20% sucrose gradient. Viral titer was determined using a Retrotek HIV-1 p24 antigen ELISA kit (ZeptoMetrix). Cultured THY1þ germ cells were transduced with either non-targeting control or Neurog3-specific shRNA lentivirus (at a multiplicity of infection of 5) in the presence of hexadimethrine bromide (Polybrene; 8 lg/ml) for 18 h. Cells were then allowed to recover for 24 h followed by supplementation with puromycin (1 lg/ml) for 72 h to select cells with stable incorporation of the vector. Cells were allowed 24 h of recovery without puromycin treatment prior to collection for transplantation into recipient testes or RNA extraction. To examine changes in transcript abundance, RNA was isolated using TRIzol reagent (Invitrogen), and relative Neurog3 transcript abundance was evaluated by TaqMan qRT-PCR assays.
Transfection of Cultured THY1þ Germ Cells with siRNA Oligonucleotides
Cultured THY1þ germ cells from Rosa donors were transfected with 75 pmol of validated ON-Target plus siRNA oligonucleotides (non-targeting control or Neurog3-specific; Dharmacon) per 1 3 10 5 cells for 24 h, using Lipofectamine 2000 reagent (Invitrogen) in Opti-Minimal Essential Media (Opti-MEM; Invitrogen). Medium was then replaced with mSFM supplemented with GDNF and FGF2. To examine changes in transcript abundance, we isolated RNA from transfected cells at 24 h and 7 days after treatment, using TRIzol reagent (Invitrogen). Relative Neurog3 transcript abundance was evaluated by TaqMan qRT-PCR.
Treatment of Cultured THY1þ Germ Cells with Cell Permeable-Inhibiting Peptides
Cultured THY1þ germ cells from Rosa donors were treated with a STAT3-specific inhibitor peptide or inactive control peptide (Sigma-Aldrich) at a concentration of 5 ng/ll for 24 or 72 h. The STAT3-specific inhibitor peptide interferes with the ability of STAT3 to form functional dimeric complexes, thereby disrupting its transcription factor activity [16] . To examine changes in transcript abundance, we isolated RNA at 24 and 72 h after treatment, using TRIzol reagent (Invitrogen). Relative Neurog3 and Bcl6b transcript abundance levels were evaluated by TaqMan qRT-PCR.
qRT-PCR Analyses
RNA was extracted from cells by using TRIzol reagent (Invitrogen) according to the manufacturer's instructions, and RNA concentration and purity (as determined by 260/280-nm absorbance reading ratios) were measured using a NanoDrop 2000 spectrophotometer (Thermo Scientific). Only samples with a 260/280-nm ratio of greater than 1.75 were used for qRT-PCR analyses. Genomic DNA was eliminated by treatment with DNase I. For each sample, 1 lg of RNA was reverse transcribed with oligo(d)T priming by using a Super Script III reverse transcriptase kit (Invitrogen). Relative Neurog3, Stat3, and Bcl6b gene expression levels were determined using validated TaqMan gene expression assays and a 7500 Fast Real-Time PCR system (Applied Biosystems). To make quantitative comparisons between samples, we normalized Neurog3, Stat3, and Bcl6b expression to expression of the constitutively expressed ribosomal protein S2 (Rps2) gene. Relative transcript abundance was determined using the formula: relative transcript abundance ¼ 0.5 ([Ct of the gene-of-interest] -[Ct of Rps2]) [8] .
Western Blot Analyses
Protein lysates were isolated from cultured cells by using mammalian protein extraction reagent (Thermo Scientific). Protein concentration of each lysate was determined using the BCA protein assay (Pierce Protein Research), and 25 lg of protein was loaded per well in Novex 4%-12% bis-Tris gels (Invitrogen). Gel electrophoresis was conducted using an XCell SureLock Mini-Cell electrophoresis system (Invitrogen) at 200 V for 60 min. Proteins were transferred from to nitrocellulose membranes (Bio-Rad Laboratories) using the XCell II blot module (Invitrogen) at 30 V for 90 min. Blots were then blocked for nonspecific antibody binding by incubation with 5% bovine serum albumin in Tris-buffered saline with 0.1% Tween-20 (TBS-T) for 2 h at room temperature with gentle shaking. Blots were probed with rabbit anti-mouse p-STAT3 Tyr705 primary antibody (1:2000 dilution; Cell Signaling Technology) or rabbit anti-mouse NEUROG3 (1:500 dilution; Santa Cruz Biotechnology) overnight at 48C with gentle shaking followed by washing with TBS-T. The next day, blots were incubated with secondary goat anti-rabbit IgG antibody conjugated to horseradish peroxidase (HRP; 1:5000 dilution; Santa Cruz Biotechnology) for 2 h at room temperature with gentle shaking, followed by washing in TBS-T. HRP activity was detected using PicoWest chemiluminescence detection reagent (Pierce Protein Research). Digital images were captured after 30 sec of exposure by using a ChemiDoc XRS molecular imaging system (Bio-Rad Laboratories). Blots were then stripped of antibodies by using Restore Western blot stripping buffer (Fisher Scientific) for 15 min and were again blocked against nonspecific antibody binding. For normalization, total STAT3 expression was examined by incubating blots with primary rabbit anti-human STAT3 antibody (1:1000 dilution; Cell Signaling Technologies) or rabbit antimouse TUBULIN-b (1:10000 dilution; Novus Biologicals) overnight at 48C and with secondary goat anti-rabbit IgG antibody conjugated to HRP (80 ng/ ml; Santa Cruz Biotechnology) for 2 h at room temperature. HRP activity was detected, and digital images were taken after 15 sec of exposure. Densitometric analysis of bands was conducted using Quantity One software (Bio-Rad Laboratories), and expression levels of p-STAT3 Tyr705 protein were compared between samples based on the normalized ratio of p-STAT3 Tyr705 to total STAT3.
Statistical Analyses
Data are presented as means 6 SEM for at least three replicates of each experiment. Differences between means of treatment groups were examined using the univariate analysis of variance or t-test function in GraphPad Prism 5. Multiple comparisons were conducted using Bonferroni post hoc test for significance with repeated measures function. A P value of 0.05 was considered significantly different.
RESULTS
Inhibition of STAT3 Function Corresponds to Reduced Neurog3 Gene Expression in Cultured THY1þ Undifferentiated Spermatogonia
Our previous studies showed that STAT3 plays an important role in regulating the differentiation of both SSC and progenitor spermatogonia [9] , and an increase of Neurog3 expression coincides with development of progenitor spermatogonia [10] . Here we explored whether expression of the two molecules is correlated in cultured THY1þ spermatogonia. These cultures consisted of germ cell clumps containing SSCs, which colonized recipient testes after transplantation and nonstem cell progenitor spermatogonia (Fig. 1, A and B) . Examination of the cultured germ cell clumps as single cells, using immunocytochemical staining, revealed that ;30% of the cells expressed NEUROG3 (Fig. 1C) . Similarly, we found that NEUROG3þ cells consisted of ;30% and ;28% of THY1þ germ cell fractions isolated from pup and adult testes, NEUROG3 REGULATES DIFFERENTIATION OF SSC respectively (Supplemental Fig. S1 ; all Supplemental Data are available online at www.biolreprod.org). Western blot analyses with protein lysates from adult mouse testes and cultured THY1þ spermatogonia detected a single band of ;21 kDa, and detectable expression decreased in cultured THY1þ spermatogonia after treatment with Neurog3-specific siRNA, thereby verifying specificity of the antibody for detection of NEUROG3 protein (Supplemental Fig. S1 ). Co-immunofluorescent staining showed that in cultured THY1þ germ cell populations, all NEUROG3þ cells also stained for expression of the active form of STAT3 phosphorylated at Tyr705 (Fig.  1C) , suggesting a connection between expression of NEU-ROG3 and the presence of activated STAT3. Furthermore, Neurog3 transcript abundance in cultured cells treated with Stat3-specific siRNA (;80% reduction of Stat3 expression) was found to be significantly reduced (P 0.05) by ;25% and 40% after 24 and 72 h of treatment, respectively, compared to cells treated with control siRNA (Supplemental Fig. S2 ). To assess whether the effect of Stat3 knock-down was specific to Neurog3, we also measured expression of Bcl6b, which is expressed by SSC and known to regulate their self-renewal [7] . After both 24 and 72 h of treatment, Bcl6b transcript abundance was found to be no different (P . 0.05) in Stat3-specific siRNA-treated cells compared to control siRNAtreated cells (Supplemental Fig. S2 ). These results indicated that Stat3 signaling is critical for Neurog3 gene expression in cultured SSC and progenitor spermatogonia. To confirm this interaction, we measured Neurog3 transcript abundance in cultured THY1þ spermatogonia treated with a STAT3-specific inhibiting peptide, which blocks dimerization, thereby preventing binding to DNA and transcription factor activity [16] . Our previous studies showed that treatment with the STAT3-inhibiting peptide or control peptide does not significantly affect survival of cultured THY1þ spermatogonia, but SSC content is significantly increased in STAT3-inhibiting peptidetreated cultures [9] . The abundance of Neurog3 transcript was found to be significantly (P 0.05) reduced by 24.9 6 2.6% (n ¼ 3 independent experiments) 24 h after treatment and even further by 66.9 6 3.8% (n ¼ 3 different experiments) at 72 h after treatment in cells treated with STAT3-specific inhibiting peptide compared to those treated with control peptide (Fig.  1D) . Importantly, Bcl6b transcript abundance was not different (P . 0.05) between cells treated with STAT3-specific inhibitor or control peptide at either 24 or 72 h of treatment (Fig. 1D) . Collectively, these findings indicate that STAT3 regulates the expression of NEUROG3 in SSC and progenitor spermatogonia thus linking the two molecules in a possible molecular pathway controlling differentiation. KAUCHER ET AL.
GDNF Signaling Suppresses Both Phosphorylation of STAT3 and Neurog3 Gene Expression in Cultured THY1þ Undifferentiated Spermatogonia
Next, we explored whether STAT3 and Neurog3 were linked in a pathway that controls the differentiation of SSC and progenitor spermatogonia by investigating the effects of GDNF signaling on activation of STAT3 protein and, in turn, Neurog3 gene expression. Previous studies showed that GDNF is an essential regulator of SSC self-renewal both in vivo and in vitro [5, 6] . In particular, supplementing cultures of THY1þ spermatogonia with GDNF promotes the self-renewal of SSCs for long periods of time [11] . Here we examined whether exposure to GDNF influences the phosphorylation of STAT3 protein which is required for formation of functional dimeric transcription factor complexes [17, 18] and Neurog3 gene expression in cultures of THY1þ spermatogonia. Both phosphorylated STAT3 and NEUROG3 are present in cultured THY1þ spermatogonia in the presence of exogenous GDNF, but we reasoned that their levels may be altered based on the activity of GDNF signaling. Withdrawal of GDNF for 18 h resulted in a significant (P 0.05) increase of phosphorylated STAT3 levels, which were subsequently suppressed upon replacement of GDNF for 4 h (Fig. 2, A and B) . In accordance, Neurog3 transcript abundance was found to be significantly (P 0.05) increased after GDNF withdrawal and suppressed upon replacement (Fig. 2C) . These findings imply that Neurog3 gene expression is regulated by STAT3 activation in SSC and progenitor spermatogonia. Furthermore, in previous studies we found that genes up-regulated by GDNF signaling are important regulators of SSC self-renewal [7] ; thus, these results also suggest that Neurog3 is an important regulator of SSC differentiation.
STAT3 Binds the Neurog3 Promoter/Enhancer Region in THY1þ Undifferentiated Spermatogonia and Drives Transcription
The above results suggested that STAT3 regulates Neurog3 gene expression in SSC and progenitor spermatogonia, but a direct connection was not made. To investigate this further, we used a ChIP method to determine whether STAT3 binds Neurog3 regulatory elements in THY1þ spermatogonia. Examination of the reported nucleotide sequence for the distal promoter/enhancer region of Neurog3 (NCBI RefSeq accession no. NC_000076.5) revealed a canonical STAT3 binding site of TTGGNCCAA (Fig. 3A) . Using a validated STAT3-specific antibody, we immunoprecipitated STAT3-DNA complexes from freshly isolated THY1þ spermatogonia. PCR analysis with primers designed to span a 200-bp segment of the Neurog3 distal promoter/enhancer region including the STAT3 binding site produced an amplicon of expected size; whereas, control samples that included normal rabbit IgG in place of primary antibody for immunoprecipitation did not produce an amplicon (Fig. 3B) . In addition, PCR analysis with primers spanning a portion of the Myc promoter, which is a known target region for STAT3 binding [12] , also produced an amplicon, thereby validating accuracy of the ChIP procedure (Fig. 3B) . Moreover, quantitative ChIP analyses revealed that the amount of Neurog3 promoter/enhancer DNA bound by activated STAT3 in cultured THY1þ spermatogonia correlated to treatment effects that alter Neurog3 transcript abundance (Fig. 3C) . Withdrawal of GDNF signaling for 18 h leads to increased STAT3 activation and Neurog3 transcript abundance, and this response is suppressed after 4 h of GDNF replacement (Fig. 2) , Correspondingly, the amount of Neurog3 promoter/ enhancer DNA immunoprecipitated with a STAT3-specific antibody was significantly (P 0.05) greater from cells after GDNF withdrawal than in cells continually exposed to GDNF, Data are presented as the fold-difference compared to cells continually supplemented with GDNF (þGDNF) for the ratio of p-STAT3 Tyr705 -to-total STAT3 and are means 6 SEM for three independent experiments with different cultures. *Significantly different at P 0.05. After 18 h withdrawal of GDNF, the level of p-STAT3 Tyr705 increased significantly and was subsequently suppressed after 4 h of GDNF replacement. C) qPCR analyses for Neurog3 transcript abundance in cells continually exposed to GDNF (þGDNF), subjected to 18 h of withdrawal of GDNF (ÀGDNF 18 h), and after 4 h of GDNF replacement following 18 h of withdrawal (ÀGDNF 18 h/þGDNF 4 h). Data are presented as fold-difference compared to cells continually supplemented with GDNF and are mean 6 SEM for three independent experiments with different cultures. *Significantly different at P 0.05. After 18 h withdrawal of GDNF supplementation, expression of Neurog3 was increased significantly and subsequently suppressed following 4 h of GDNF replacement.
NEUROG3 REGULATES DIFFERENTIATION OF SSC
and replacement of GDNF for 4 h suppressed the increased binding (Fig. 3C) . Furthermore, the amount of Neurog3 promoter/enhancer DNA immunoprecipitated from cells treated with a STAT3-specfic inhibiting peptide for 24 h, which leads to significant reduction of Neurog3 transcript abundance (Fig. 1) , was significantly (P 0.05) reduced compared to cells treated with a control peptide (Fig. 3C) .
Next, we determined whether STAT3 directly regulates Neurog3 promoter/enhancer activity. To investigate this, we used a reporter construct in which the Neurog3 promoter/ enhancer sequence was cloned upstream of the firefly luciferase gene, termed pNeurog3-Luc [15] . The transfection efficiency of cultured SSC/progenitor spermatogonia with plasmid DNA vectors is low, thus HeLa cells were used with the reporter vector to determine whether STAT3 is capable of stimulating Neurog3 promoter/enhancer activity. First, we examined whether STAT3 is phosphorylated in HeLa cells which is required for its transcription factor activity. The level of phosphorylated STAT3 was found to be low in basic media conditions but greatly increased after treatment with recombinant IFNA (Supplemental Fig. S3) . Transient transfections were then carried out with the pNeurog3-Luc construct in IFNA stimulated HeLa cells with cotreatment of validated STAT3-specific inhibiting or control peptides. Compared to FIG. 3 . STAT3 physically interacts with the distal Neurog3 promoter/enhancer region in SSC and progenitor spermatogonia and is capable of stimulating Neurog3 promoter activity. A) Nucleotide sequence of the distal Neurog3 promoter/enhancer region in the mouse genome (NCBI RefSeq accession no. NC_000076.5), which contains a canonical STAT3 binding site (bolded and underlined sequence). B) Representative image of PCR analyses for the Neurog3 promoter/enhancer sequence with DNA template that was immunoprecipitated from THY1þ germ cells using a STAT3-specific antibody. Primer sequences for the Neurog3 promoter/enhancer are identified by bold in A. PCR analyses with primers for the Myc promoter which is a known target of STAT3 and input DNA prior to immunoprecipitation with primers for the Neurog3 promoter/enhancer were used as positive controls. Use of normal IgG instead of STAT3-specific antibody for immunoprecipitation served as a negative control. STAT3 was found to bind both the Neurog3 promoter/enhancer and Myc promoter sequences within THY1þ spermatogonia. C) Quantitative ChIP analyses for STAT3 occupancy of the Neurog3 promoter/enhancer region in cultured THY1þ spermatogonia following treatments that alter Neurog3 transcript abundance. Cells were continually cultured with GDNF (þGDNF), subjected to withdrawal of GDNF for 18 h (ÀGDNF 18 h), or subjected to replacement of GDNF for 4 h after 18 h withdrawal (ÀGDNF 18 h/ þGDNF 4 h). Also, cells were treated with control inhibiting peptide or STAT3-specific inhibiting peptide for 24 h. Data are presented as mean 6 SEM of three independent experiments with different primary cultures. *Significantly different at P 0.05. D) Luciferase activity in HeLa cells stimulated with INFA to activate STAT3 following transfection with an empty luciferase reporter vector (Empty Vector) or reporter vector in which the Neurog3 promoter sequence was cloned upstream of the firefly luciferase gene and treated with a control or STAT3-specific inhibiting peptide. Data are presented as RLU, which was derived from normalization to a Renilla luciferase internal control vector and are means 6 SEM for four independent experiments. *Significantly different at P 0.05. NT, cells receiving no treatment; a representation of background luminescent signal. Addition of the Neurog3 promoter construct into IFNA stimulated HeLa cells treated with a control peptide resulted in a significant increase of luciferase activity, whereas inclusion of a STAT3-specific inhibitor peptide suppressed the promoter activity.
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cells transfected with a control pLuc vector, transfection with pNeurog3-Luc and control peptide treatment resulted in a significant (P 0.05) increase of luciferase activity by greater than 5-fold and this response was significantly (P 0.05) suppressed in cells treated with STAT3-specific inhibiting peptide (Fig. 3D) . Collectively, these results imply that STAT3 is a direct regulator of Neurog3 transcription in THY1þ spermatogonia further suggesting these molecules are linked in a mechanism controlling the differentiation of SSC and progenitor spermatogonia in the mammalian germline.
Transient Reduction of Neurog3 Expression Enhances SSC Self-Renewal In Vitro
In previous studies, we found that reduction of STAT3 expression in cultures of THY1þ spermatogonia with siRNA treatment led to an increase of SSC content without effecting overall proliferation or survival of spermatogonia [9] . Those findings indicated a change in the balance of self-renewal and differentiation of SSCs that occurs in cultures of THY1þ spermatogonia to favor self-renewal, thus producing greater stem cell content when STAT3 expression is impaired. The above results showing that STAT3 regulates expression Neurog3 in THY1þ spermatogonia suggested that NEUROG3 also plays an important role in SSC differentiation. To explore this possibility further, we subjected cultures of THY1þ spermatogonia to 24 h of treatment with Neurog3-specific or control siRNA every 7 days to transiently reduce expression and measured SSC content by transplantation analysis after 7 and 14 days of culture (Fig. 4A) . Previous studies showed that SSCs self-renew at a rate of ;6 days in these cultures [11] , thus our analyses examined SSC content after greater than 2
FIG. 4. Inhibition of Neurog3 enhances the self-renewal of SSCs in vitro.
A) Experimental strategy for examining the impact of Neurog3 deficiency on self-renewal of SSCs in vitro. Cultured THY1þ germ cells were treated with Neurog3-specific or control siRNA for 24 h and after another 6 days an aliquot of the cell population was transplanted into recipient testes to measure stem cell content. The remaining cells were again treated with Neurog3-specific or control siRNA for 24 h and cultured another 6 days followed by transplantation to measure stem cell content. The proliferation rate of SSCs within cultures of THY1þ germ cells is ;6 days. Thus, these analyses allowed for determining stem cell content after .2 self-renewal cycles. B) qPCR analyses for Neurog3 gene expression in cultured THY1þ germ cells 24 h and 7 days after treatment with Neurog3-specific or control siRNA. Data are presented as fold-difference compared to control siRNA treatment and are mean 6 SEM for three independent experiments with different cultures. *Significantly different at P 0.05. Neurog3 transcript abundance was significantly reduced 24 h after treatment and was not different after 7 days, indicating transient reduction by siRNA treatment. Furthermore, there was no difference in expression at the time of transplantation on Days 7 and 14 of culture. C) SSC content in cultures of THY1þ germ cells treated with Neurog3-specific or control siRNA at 0, 7, and 14 days of culture. SSC concentrations were determined based on the number of colonies of rederived spermatogenesis in recipient testes per 1 3 10 5 cells transplanted. Data are presented as folddifference compared to control siRNA treated cells and are mean 6 SEM for three independent experiments with different cultures. *Significantly different at P 0.05. At Day 14, which is greater than two SSC self-renewal cycles in vitro, SSC concentration was significantly increased in cultures treated with Neurog3-specific siRNA. D) Total number of cells in cultures of THY1þ germ cells treated with Neurog3-specific or control siRNA at 0, 7, and 14 days of culture. Data are presented as fold-difference compared to control siRNA treatment and are mean 6 SEM for the same three independent experiments with the same cultures used for transplantation analyses. *Significantly different at P 0.05. No difference in total germ cell content was found between Neurog3-specific and control siRNA treated cultures at any of the time points examined.
NEUROG3 REGULATES DIFFERENTIATION OF SSC
self-renewal cycles. Transfection of cultured THY1þ germ cells derived from Rosa donor mice that express the LacZ marker transgene in all germ cells with Neurog3-specific siRNA resulted in a significant (P 0.05) reduction of Neurog3 expression by ;58% after 24 h of treatment compared to cells transfected with non-targeting control siRNA (Fig. 4B) . This response was transient and 7 days posttreatment Neurog3 transcript abundance was not different (P . 0.05) between cells treated with Neurog3-specific or control siRNA (Fig. 4B) . Transplantation analysis revealed that SSC content was marginally increased 1.1-fold in Neurog3-specific siRNA treated cultures compared to control-treated cells 7 days after treatment (n ¼ 3 independent experiments with different THY1þ germ cell cultures and 18 recipient testes for each treated spermatogonial population); however, after 14 days (i.e., two self-renewal cycles) SSC content was increased 2.2-fold (n ¼ 3 independent experiments with different THY1þ germ cell cultures and 18 recipient testes for each treated spermatogonial population) in Neurog3-specific siRNA treated cultures compared to control siRNA treated cultures (Fig. 4C ). While differences in SSC content were found, the total number of germ cells in Neurog3-specific siRNA treated cultures compared to controls was not different (P . 0.05) at either 7 or 14 days of culture (Fig. 4D) . SSC division has the potential to produce new SSCs via self-renewal and generate non-stem cell progenitor spermatogonia. Under steady-state conditions, the balance between these fates should be equal. Therefore, a change in SSC content without associated difference of total germ cell number indicates alteration in the balance of fate decisions. In this respect, increase of SSC content following impairment of Neurog3 expression suggests alteration of the balance to favor self-renewal. Together, these results indicate that NEUROG3 plays an important role in regulating SSC differentiation to generate progenitor spermatogonia.
SSC and Progenitor Spermatogonia Deficient for Neurog3 Expression Are Incapable of Differentiation In Vivo
Next, we aimed to determine whether expression of Neurog3 is required for the differentiation of SSC and progenitor spermatogonia in vivo. Global inactivation of Neurog3 results in neonatal lethality [19] , thus precluding the ability to study an importance for spermatogonial development in testes of adult animals. In previous studies examining the function of STAT3 we found that lentiviral vectors are effective for driving expression of a shRNA transgene in THY1þ spermatogonia to permanently reduce expression of specific transcripts [9] . Following transplantation into seminiferous tubules of recipient mice, we found that cultured SSC and the progenitor spermatogonia deficient for expression of Stat3 were unable to differentiate [9] . Thus, we reasoned that if NEUROG3 functions as a critical downstream effector of STAT3 to regulate differentiation, forced expression of a Neurog3-specific shRNA targeting transgene via lentiviral KAUCHER ET AL. transduction in THY1þ spermatogonia would also impair differentiation in vivo. We generated Neurog3-specific and non-targeting control shRNA lentiviral vectors from validated commercially available plasmids (Sigma-Aldrich). Cultured LacZ expressing Rosa THY1þ spermatogonia were then transduced with the lentiviral vectors and subjected to puromycin treatment to select cells with stable integration of shRNA transgenes. Neurog3 transcript abundance in Neurog3-specific shRNA treated cells was found to be significantly (P 0.05) reduced by ;86% compared to cells treated with control shRNA (Fig. 5A) . Next, we transplanted Neurog3 and control shRNA-treated Rosa THY1þ germ cells into the seminiferous tubules of recipient mice to assess their ability for differentiation leading to regeneration of spermatogenesis. Evaluation at 2 months after transplantation revealed complete regeneration of spermatogenesis by THY1þ germ cells treated with the control shRNA vector which was evident by the dark blue staining in recipient seminiferous tubules (Fig. 5B) . In stark contrast, only short chains and single spermatogonia formed from Neurog3-specific shRNA treated cells (Fig. 5, C  and D) . Colonies of complete spermatogenesis were not observed in any of the testes transplanted with Neurog3-specific shRNA treated cells (n ¼ 6 testes examined). These results demonstrate that proper expression of Neurog3 is required for differentiation of SSC and progenitor spermatogonia. Moreover, they are identical to our previous observations from Stat3-specific shRNA treatment of cultured THY1þ spermatogonia, further indicating that these molecules are critical components of the molecular mechanism controlling differentiation of SSC and progenitor spermatogonia in the mammalian germline.
DISCUSSION
Although many regulators of SSC self-renewal and maintenance have been described [6-8, 11, 20-22] , the understanding of mechanisms controlling differentiation are rudimentary. The rarity of SSCs within the male germline poses a major challenge for dissecting molecular pathways in vivo. Therefore, in this study we used the THY1þ germ cell fraction in mouse testes for investigation because it is enriched for SSC and progenitor spermatogonia compared to the total testis cell population [6] . Thus, this fraction is an excellent representation of the undifferentiated spermatogonial population. Moreover, THY1þ germ cells can be maintained in vitro as a proliferative population in which both SSC and progenitor spermatogonial components are present, thereby providing a model to identify molecular regulators of differentiation and manipulate their expression. Here, we utilized these tools to uncover a novel mechanism whereby STAT3 up-regulates expression of NEUROG3 which subsequently plays an essential role in controlling the differentiation of SSC and progenitor spermatogonia.
Previous studies showed that genes up-regulated by GDNF stimulation influence self-renewal and survival of SSCs [7, 8] .
Here we show that expression of Neurog3 is suppressed by GDNF stimulation, suggesting a role in regulating the initial differentiation of SSCs to generate progenitor spermatogonia. We found that activation of both STAT3 and Neurog3 gene expression increase in cultures of THY1þ spermatogonia after withdrawal of GDNF and are suppressed upon reexposure. These findings indicate that a pathway of differentiation is activated upon withdrawal or diminishment of growth factor signaling that regulates self-renewal. However, in a previous study we found that the number of cells capable of regenerating spermatogenesis following transplantation into testes of busulfan-treated recipient mice was increased in cultured THY1þ undifferentiated spermatogonial populations subjected to 18 h withdrawal of GDNF [7] . Those findings indicated that SSCs are more receptive to colonization when an extended period of GDNF exposure is followed by a short period of withdrawal. This phenomenon could be the result of a stress response that enhances homing of SSCs to accessible niches, thereby altering colonization efficiency. Considering that testes of busulfan-treated mice contain elevated levels of GDNF [23] , it is possible that SSC hypersensitivity to this factor following withdrawal from persistent exposure in vitro enhances colonization efficiency upon transplantation. It remains to be explored whether increased activation of STAT3 and upregulation of Neurog3 gene expression following GDNF withdrawal are related to enhanced colonization efficiency of SSCs or whether these are merely associated observations.
In previous studies, we found that the transcription factor STAT3 was required for development of progenitor spermatogonia from SSCs [9] , and in the current study, we uncovered a similar role for NEUROG3. Transient inhibition of Neurog3 expression in cultures of THY1þ undifferentiated spermatogonia resulted in an increase of stem cell content after 14 days of culture without affecting the total number of spermatogonia being maintained. The self-renewal rate of SSCs in vitro is ;6 days [11] , thus these results indicate that impairment of NEUROG3 expression significantly altered the ratio of stem cell to non-stem cell spermatogonia after greater than 2 selfrenewal cycles. The lack of change in total spermatogonial number implies that neither cell survival nor overall proliferation was affected. Therefore, the change in ratio of cell types was likely due to a decrease in the initial differentiation of SSCs to produce progenitors that lack stem cell capacity, thereby increasing stem cell content of the heterogeneous germ cell clumps. Use of the germ cell transplantation method was critical for uncovering this role of NEUROG3 in undifferentiated spermatogonia; simply counting the number of germ cell clumps that formed within the culture well after experimental manipulation would have indicated no effect on SSC differentiation. Thus, these findings highlight the need to conduct functional transplantation experiments as an end-point of analysis when examining mechanisms regulating the functions of SSC and progenitor spermatogonia.
Mice containing null alleles for Neurog3 die postnatally by 3 dpp, thereby precluding the ability to use this model for studying the role of NEUROG3 in tissue lineages of adult animals [19] . To overcome this limitation, we used a lentivirusbased shRNA approach to create SSC and progenitor spermatogonia deficient for Neurog3 expression to study its importance in the mammalian germ cell lineage. After being transplanted into recipient seminiferous tubules, these cells remained as single spermatogonia or formed short chains indicating only an inability to differentiate beyond the SSC and progenitor spermatogonial stages of germline lineage development. This phenotype mimics that of SSC and progenitor spermatogonia deficient for Stat3 expression [9] , indicating that NEUROG3 is a major downstream effector of this signaling pathway. Additional analysis revealed that Neurog3 gene expression is reduced in cultured THY1þ spermatogonia upon transient impairment of STAT3 transcription factor function. Moreover, using a ChIP approach we found that STAT3 physically interacts with the distal Neurog3 promoter/ enhancer in THY1þ undifferentiated spermatogonia and using a reporter construct show that STAT3 regulates transcription through this promoter. Together, these findings indicate that Neurog3 gene expression is a downstream target of STAT3 NEUROG3 REGULATES DIFFERENTIATION OF SSC signaling in SSC and progenitor spermatogonia and these molecules are linked in a pathway controlling differentiation.
During steady-state spermatogenesis, the expression level and activity of molecules influencing formation of progenitor spermatogonia must be suppressed in SSCs during self-renewal and reach a threshold of expression or become activated in a temporal manner to induce transition and further differentiation. Previous studies showed that GDNF signaling regulates SSC self-renewal [6] [7] [8] 11] , and here we found that the level of Neurog3 gene expression is suppressed in cultured SSCs upon exposure to GDNF. Interestingly, GDNF signaling does not alter the level of Stat3 transcription in these cultures [7] , indicating that the mechanism of suppression is likely not through regulation of STAT3 protein abundance. The transcription factor activity of STAT3 requires phosphorylation to form homodimers or heterodimer complexes with other STAT molecules [17, 18] . In the current study, we show that the levels of phosphorylated STAT3 and, accordingly, Neurog3 transcript abundance in cultured SSC and progenitor spermatogonia increased when GDNF signaling was withdrawn and subsequently decreased upon replacement of exogenous GDNF to culture medium. These results indicate that GDNF signaling suppresses Neurog3 expression in SSC and progenitor spermatogonia via preventing the phosphorylation of STAT3. Interestingly, previous studies revealed that NEU-ROG3 expression increases in undifferentiated spermatogonia as they progress from A s to A al spermatogonia while expression of GDNF family receptor alpha 1 (GFRA1) decreases [24] . Collectively, these findings suggest that the removal or diminishment of GDNF signaling permits the triggering of a mechanism that leads to formation and further development of A pr /A al progenitor spermatogonia by increasing STAT3 activation to subsequently up-regulate NEUROG3 expression.
Here we show that STAT3 binds Neurog3 regulatory elements in THY1þ spermatogonia and influences the transcriptional activity of this promoter in a luciferase reporter construct when transfected into HeLa cells. Furthermore, using a quantitative ChIP approach, we found that STAT3 occupancy of the Neurog3 promoter is correlated with the abundance of Neurog3 transcript in cultured THY1þ spermatogonia. Levels of activated STAT3 protein and Neurog3 transcript were found to increase upon withdrawal of GDNF signaling, and, in accordance, the amount of Neurog3 promoter DNA pulled down with a STAT3 antibody also increased. Upon replacement of GDNF signaling, a reverse response was observed for all experimental approaches. Collectively, these findings imply that STAT3 directly regulates Neurog3 transcription in SSC and progenitor spermatogonia.
In accordance with the removal of a mechanism suppressing STAT3 activation upon withdrawal of GDNF signaling, other extrinsic stimuli must signal to promote STAT3 phosphorylation. While the inducer of STAT3 phosphorylation in male germ cells is currently unknown, the cytokine leukemia inhibitory factor (LIF) is known to be a potent activator of STAT3 phosphorylation in pancreatic precursor cells during beta cell transdifferentiation and neogenesis [25] [26] [27] . Studies by Kanatsu-Shinohara and colleagues [28] found that addition of LIF to cultures of undifferentiated spermatogonia also supplemented with GDNF enhances formation of germ cell clumps containing SSC and progenitor spermatogonia but does not alter stem cell proliferation or content. These findings suggest that LIF signaling promotes the development of nonstem cell progenitor spermatogonia without effecting SSC selfrenewal. In the current study, THY1þ undifferentiated spermatogonia containing SSC and progenitor spermatogonia were cocultured with LIF-secreting STO feeder cell monolayers, thereby providing a potential stimulus for STAT3 activation. Thus, it is plausible to postulate that LIF signaling in SSC and progenitor spermatogonia in vivo activates STAT3 to drive expression of NEUROG3 to a threshold level that promotes differentiation when GDNF signaling is reduced or lost; whereas, activation of GDNF signaling in SSCs suppresses this pathway below a threshold level of NEUROG3 expression to promote self-renewal.
While our studies and those of others have shown that NEUROG3 regulates the differentiation of multiple stem/ progenitor cell populations, the mechanism of action is unclear. However, the molecular classification of NEUROG3 as a bHLH transcription factor provides some insight. In general, these transcription factors form heterodimeric complexes with ubiquitously expressed E proteins which subsequently bind E box elements within promoters of target genes to regulate transcription [29, 30] . Studies of the pancreatic endocrine cell lineage revealed a variety of genes whose expressions are tied to NEUROG3 transcriptional activation including neurogenic differentiation 1 (Neurod1) [19, 31, 32] , ISL1 transcription factor LIM/homeodomain (Isl1) [19] , paired box gene 4 (Pax4) [19, 32] , and paired box gene 6 (Pax6) [19, 32] . Scanning of microarray gene expression databases for mouse undifferentiated spermatogonia indicates that these genes are not expressed [8] . Thus, the majority of downstream targets of NEUROG3 transcriptional regulation in the male germline are either distinct from those in pancreatic precursors or become expressed later in germ cell development when transition to differentiating spermatogonia occurs.
Because of the apparently essential role in regulating differentiation and studies by Nakagawa et al. [31] showing that at least some SSCs express NEUROG3, it is likely that repressive pathways exist in SSCs during the process of selfrenewal to prevent NEUROG3 functions thereby maintaining a stem cell phenotype. Prime candidates for such repressors are the inhibitor of DNA binding (ID) proteins which bind to and in so doing sequester interacting E protein partners away from tissue-specific bHLH proteins [33, 34] . Our recent studies identified the transcriptional repressor inhibitor of DNA binding 4 (ID4) as an important regulator of SSC self-renewal [22] . Thus, it is feasible to postulate that ID4 represses NEUROG3 function in self-renewing SSCs, and differentiation is initiated when ID4 expression is reduced allowing NEUROG3/E protein complexes to form and drive the expression of genes influencing differentiation. Interestingly, GDNF signaling up-regulates ID4 expression and was shown in this study to suppress the levels of activated STAT3 in SSC and progenitor spermatogonia. Thus, in vivo it is possible that reduced GDNF signaling in SSC and progenitor spermatogonia results in reduction of ID4 levels and removal of suppression permits an increase of activated STAT3 to a threshold level allowing NEUROG3 levels to also increase, form heterodimeric complexes with E proteins and subsequently bind accessible E box regulatory elements in DNA.
Disruption of stem cell functions results in loss of tissue homeostasis. Thus, deciphering mechanisms regulating stem cell differentiation could provide valuable information for diagnosing and treating a variety of degenerative diseases. Previous studies showed that NEUROG3 is an important regulator of differentiation for multiple progenitor cell populations [19, [35] [36] [37] [38] . In particular, STAT3 activation via LIF signaling in pancreatic precursors appears to influence Neurog3 transcription which subsequently plays an essential role in specification of beta cells [26] . In addition, expression of NEUROG3 influences differentiation of neural progenitors KAUCHER ET AL. [35] , and formation of the gastric endocrine cell lineage [39, 40] . Results of the current study add to the defining role of NEUROG3 as a regulator of differentiation by showing that expression is important for both the initial formation of progenitor spermatogonia from SSCs and their subsequent further differentiation. Thus, it is feasible to postulate that impairment of NEUROG3 expression may be an underlying cause of degenerative disease in a variety of tissues including disruption of spermatogenesis leading to subfertility or infertility in men.
